# Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD

> **NCT04055883** · PHASE2 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 228 (actual)

## Conditions studied

- Calcific Aortic Valve Disease

## Interventions

- **DRUG:** DA-1229

## Key facts

- **NCT ID:** NCT04055883
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-26
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-02-01
- **Target enrollment:** 228 (ACTUAL)
- **Last updated:** 2023-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04055883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04055883, "Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04055883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*